What the fee buys, and what it does not
The published figure is a per-consultation charge for a weight-loss visit. The footnote beside it says the visit covers the consultation only and that the cost of labs is excluded. Nothing about the medication is inside it.
Six of the seventy-three sellers here publish a figure that is not the medication, and this is one of them. On this roster those rows carry a flag so no tool adds a care fee to a drug price or mistakes one for the other.
That makes this a different kind of listing from most of the comparison. The question it answers is what an eligibility appointment costs, not what a month of treatment costs, and the second question is not answered anywhere on the page.
The lower number on the page is somebody else's
The page also carries a much lower figure for the medication itself. Read the footnote: it applies with a manufacturer coupon, without insurance, at participating pharmacies of the reader's choosing, subject to eligibility, and the page adds that the cash price may be higher.
That is a reference to a manufacturer programme, published by a third party. It is not this seller's price and it is not recorded as one. Two rows on this roster now publish manufacturer self-pay ladders directly, which is where a figure of that kind can be checked against its source.
This is the same shape as several other rows here: a company that writes the prescription, publishes somebody else's medication figure on its own page, and charges separately for the care. The distinction between the two is the single most important thing to hold on to while reading it.
Approved medication only, and it says so
The clinicians here can prescribe FDA-approved weight-loss medications, and the page names them, covering three of the four molecules this comparison tracks. It rules compounded weight-loss medication out in writing rather than leaving the question to intake.
That list sits inside a collapsed panel a reader has to open, which is worth knowing because the unopened page reads as though it names nothing. Opening every panel adds about a fifth again to the page's visible text.
Twenty-eight of the seventy-three sellers here state that no membership applies, and this one says it in three words in the hero. A per-visit charge with no subscription is the simplest commercial shape in this comparison, and it is unusual that the simplest shape comes from the largest company in it.
What it does not name
No dispensing pharmacy is named for the medication, which is worth a line because the corporate parent owns a national pharmacy chain. The page sends a prescription to participating pharmacies of the reader's choosing, and that names nobody in particular.
Thirty-three of the seventy-three sellers here name no individual prescribing clinician, and this is one of them. The page describes a licensed provider and stops there.
Forty-one of the seventy-three sellers here publish no service area. Here the seller goes slightly further than silence and states that prescribing may not be available in all states, which is an honest warning and still not an answer. A census of the whole page with every panel opened found that sentence to be the only mention of a state at all.
One more thing about the corporate identity: the company is headquartered in one state and its terms choose the law of another. That is not a defect, but it is not the state a reader would guess from the address.
A warning letter, and it is about eye drops
Eight of the seventy-three sellers here carry a recorded FDA warning letter. This one, from September 2023, is addressed to the corporate parent's chief executive and concerns an unapproved eye-drop product offered for sale on the company's website.
It has nothing to do with weight-loss medication, with GLP-1 drugs, or with this clinic. Saying that a company on a GLP-1 comparison has an FDA warning letter, without naming the product, would be misleading by omission, so the product is named here and in the row's cons.
The number, the date and a link to the agency's own text are on this row. A warning letter is a disclosure and not a finding of guilt, and nothing here is scored down for it.
CVS MinuteClinic's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (brand) | $29A per-consultation cash fee and nothing else: "Meet with a licensed provider virtually for just $29" and "Check GLP-1 eligibility for $29", footnoted "RESTRICTIONS APPLY: $29 cash pay visit covers weight loss-related consultation only; price of labs not included." ⚠ The medication is not included and is not sold here; a prescription, if written, is filled at a pharmacy the patient chooses. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 73 providers reviewed here are paid partners today; the other 69 are not. See how this works.
See CVS MinuteClinic's current price →Good fit if
- Readers who want a cheap eligibility appointment with a prescriber who will only write approved medication.
- Buyers who have already decided where they want the prescription filled and only need someone to write it.
- People who want compounded products ruled out in writing before they book anything.
- Anyone who wants a per-visit charge with no subscription attached, stated plainly on the priced page.
Look elsewhere if
- Anyone comparing what a month of treatment costs. That figure is not published here at all.
- Readers who want the medication and the care in one bill. These are two purchases from two businesses.
- Buyers who need their state confirmed. The page warns that prescribing may not be available everywhere and lists nothing.
- People who want the dispensing pharmacy named, or an individual prescriber named.
How this review was verified
- Read the weight-loss programme page in a browser and audited every dollar element for computed opacity, visibility and a real laid-out rectangle before recording a figure.
- Opened every collapsed panel on the page one at a time, by its own visible label, and compared the visible text length before and after each, which is how the list of prescribable medications was found.
- Recorded the consultation charge with a flag saying it is not the medication, so no tool on this site can add it to a drug price or read it as one.
- Excluded the lower medication figure on the same page. Its own footnote makes it a manufacturer coupon price at pharmacies of the reader's choosing, and the page states the cash price may be higher.
- Excluded two elements that compute to hidden while still occupying real space on the layout; they belong to a different service's pricing navigation.
- Censused the whole rendered page, with every panel opened, for a state list and for state names, and found one sentence and no list.
- Took the operating company, the corporate parent, the address and the choice-of-law clause from the terms of use verbatim.
- Searched the agency's published warning-letter record for the clinic name, the pharmacy company and the parent, 2017 to 2026, with controls in the same pass, and read every returned row rather than counting them. The one letter that names this company is about an eye-drop product and is described as such. That search covers warning letters only; untitled letters are published separately and were not searched.
- Recorded that this host answers a nonexistent path with a server error rather than a not-found, at a plausible pharmacy title, so status and title were both discarded and the body was used to tell a real page from a missing one.